2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$24.43+$0.45 (+1.86%)
Price as of Aug 21, 2026 7:30 PM EDT- $174.2MMarket Cap
- -3.23%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$24.43+$0.45 (+1.86%)
CUE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.98 | ||
Change | -$0.63 (-2.56%) | ||
Open | $25.55 | ||
High | $26.00 | ||
Low | $23.23 | ||
Previous Close | $24.61 | ||
Volume | 177,749 | ||
30-Day Average Volume | 207,658 | ||
1-Week Change | -29.88% | ||
1-Month Change | -28.33% | ||
1-Year Change | -3.23% | ||
3-Year Change | -73.36% | ||
5-Year Change | -92.40% | ||
Fundamentals | |||
Shares Outstanding | 7.3M | ||
Total Assets | $30.7M | ||
Market Cap | $174.2M | ||
Enterprise Value | $166.8M | ||
Period: QTR TTM FY | |||
Revenue | $7.9M | ||
Net Income | -$153.1M | ||
Free Cash Flow | -$29.0M | ||
EBIT | -$153.1M | ||
EBITDA | -$153.0M | ||
Net Working Capital | $5.4M | ||
EPS | -$24.14 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 75 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/24/2026 | ||
Earnings & Revenue